AVEO Pharmaceuticals, Inc.

Works in GI & liver · Oncology · Renal & urogenital · Respiratory · Women's health

AVEO Pharmaceuticals, Inc. is a clinical trial sponsor. It has 3 active clinical trials with 1,390 planned participants, across 5 therapeutic areas. Since 2021 it has completed 4 trials and stopped 1 early.

Trial track record · since 2021

3Active trials1,390 planned participants
4Completed1 with results posted
1Stopped early20% of finished trials

Pipeline · 3 active trials

StageTrialStatus

On the market

1 approved drug application with a product on the market.

Questions about AVEO Pharmaceuticals, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-28.

Approve Suite is not affiliated with AVEO Pharmaceuticals, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.